DexTech Medical AB (XSAT:DEX) Other Operating Expense: kr10.48 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:DEX DexTech Medical AB XSAT:DEX
19 GF Score
Price kr10.45
! 3 Warning Signs
View Full Analysis

What is DexTech Medical AB Other Operating Expense?

DexTech Medical AB XSAT:DEX -0.95% 19 Other Operating Expense is kr10.48 Mil as of Mar. 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

DexTech Medical AB's Other Operating Expense for the three months ended in Mar. 2026 was kr3.35 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr10.48 Mil.

DexTech Medical AB's quarterly Other Operating Expense increased from Sep. 2025 (kr2.17 Mil) to Dec. 2025 (kr2.80 Mil) and increased from Dec. 2025 (kr2.80 Mil) to Mar. 2026 (kr3.35 Mil).

DexTech Medical AB's annual Other Operating Expense declined from Jun. 2023 (kr13.65 Mil) to Jun. 2024 (kr10.93 Mil) and declined from Jun. 2024 (kr10.93 Mil) to Jun. 2025 (kr8.54 Mil).

DexTech Medical AB Other Operating Expense Historical Data

* Premium members only.

The historical data trend for DexTech Medical AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB Other Operating Expense Chart

DexTech Medical AB Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.71 8.39 13.65 10.93 8.54

DexTech Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 2.16 2.17 2.80 3.35
XSAT:DEX
19GF Score
DexTech Medical AB XSAT:DEX
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr10.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of kr10.48 Mil mean?
DexTech Medical AB (XSAT:DEX) has a Other Operating Expense of kr10.48 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on DexTech Medical AB and its competitors.
Is DexTech Medical AB's Other Operating Expense too high?
DexTech Medical AB's current Other Operating Expense is kr10.48 Mil. Overall, DexTech Medical AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's Other Operating Expense compare to VRTX and REGN?
DexTech Medical AB's Other Operating Expense of kr10.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on DexTech Medical AB and its competitors. DexTech Medical AB's current Other Operating Expense is kr10.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current Other Operating Expense of kr10.48 Mil. The current Other Operating Expense is kr10.48 Mil. DexTech Medical AB's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current Other Operating Expense is kr10.48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DexTech Medical AB Business Description

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
19GF Score

Get the complete analysis for XSAT:DEX

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.45
Price